Lexicon Pharmaceuticals (LXRX) Revenue Growth (3y) (2013 - 2025)
Lexicon Pharmaceuticals (LXRX) Revenue Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 888.49 Mn | 717.83 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 837.79% |
| Dec 31, 2023 | 56.72% |
| Jun 30, 2023 | 126.63% |
| Jun 30, 2022 | -65.60% |
| Dec 31, 2020 | -81.97% |
| Jun 30, 2020 | -87.26% |
| Mar 31, 2020 | -23.64% |
| Dec 31, 2019 | -27.64% |
| Mar 31, 2019 | -41.99% |
| Dec 31, 2018 | -48.81% |
| Sep 30, 2018 | 130.88% |
| Jun 30, 2018 | 232.31% |
| Mar 31, 2018 | 141.93% |
| Dec 31, 2017 | 16.50% |
| Sep 30, 2017 | 304.22% |
| Jun 30, 2017 | 161.49% |
| Mar 31, 2017 | 301.75% |
| Dec 31, 2016 | 153.75% |
| Mar 31, 2016 | 226.19% |
| Dec 31, 2015 | 735.80% |